-
B.
Bird,
C.
Albariño,
A.
Hartman,
B.
Erickson,
T.
Ksiazek,
S.
Nichol
(2008)
Rift Valley Fever Virus Lacking the NSs and NSm Genes Is Highly Attenuated, Confers Protective Immunity from Virulent Virus Challenge, and Allows for Differential Identification of Infected and Vaccinated Animals
Journal of Virology, 82
-
K.
Kampen,
Zhongkai
Shi,
Peng
Gao,
Jianfeng
Zhang,
K.
Foster,
Dung-tsa
Chen,
D.
Marks,
C.
Elmets,
D.
Tang
(2005)
Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans.
Vaccine, 23 8
-
J.
Näslund,
N.
Lagerqvist,
M.
Habjan,
Å.
Lundkvist,
M.
Evander,
C.
Ahlm,
F.
Weber,
G.
Bucht
(2009)
Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus.
Virology, 385 2
-
P.
Hunter,
B.
Erasmus,
J.
Vorster
(2002)
Teratogenicity of a mutagenised Rift Valley fever virus (MVP 12) in sheep.
The Onderstepoort journal of veterinary research, 69 1
-
J.
Kark,
Y.
Aynor,
C.
Peters
(1982)
A rift Valley fever vaccine trial. I. Side effects and serologic response over a six-month follow-up.
American journal of epidemiology, 116 5
-
Neetu
Singh,
Aseem
Pandey,
L.
Jayashankar,
S.
Mittal
(2008)
Bovine adenoviral vector-based H5N1 influenza vaccine overcomes exceptionally high levels of pre-existing immunity against human adenovirus.
Molecular therapy : the journal of the American Society of Gene Therapy, 16 5
-
S.
Rubinchik,
J.
Woraratanadharm,
J.
Schepp,
Jian-yun
Dong
(2003)
Improving the transcriptional regulation of genes delivered by adenovirus vectors.
Methods in molecular medicine, 76
-
G.
Christopher,
G.
Christopher,
T.
Cieslak,
J.
Pavlin,
E.
Eitzen
(1997)
Biological warfare : A historical perspective
JAMA, 278
-
C.
Woods,
A.
Karpati,
T.
Grein,
N.
McCarthy,
P.
Gaturuku,
E.
Muchiri,
L.
Dunster,
A.
Henderson,
Ali
Khan,
R.
Swanepoel,
I.
Bonmarin,
Louise
Martin,
P.
Mann,
B.
Smoak,
Michael
Ryan,
T.
Ksiazek,
R.
Arthur,
A.
Ndikuyeze,
N.
Agata,
C.
Peters
(2002)
An Outbreak of Rift Valley Fever in Northeastern Kenya, 1997-98
Emerging Infectious Diseases, 8
-
J.
Morrill,
C.
Mebus,
C.
Peters
(1997)
Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle.
American journal of veterinary research, 58 10
-
P.
Vialat,
R.
Muller,
Thuy
Vu,
Christophe
Prehaud,
Michèle
Bouloy
(1997)
Mapping of the mutations present in the genome of the Rift Valley fever virus attenuated MP12 strain and their putative role in attenuation.
Virus research, 52 1
-
(2007)
Outbreak news. Rift Valley fever, Sudan.
Releve epidemiologique hebdomadaire, 82 46
-
T.
Shoemaker,
C.
Boulianne,
Martin
Vincent,
Linda
Pezzanite,
M.
Al-Qahtani,
Y.
Al-Mazrou,
Ali
Khan,
P.
Rollin,
R.
Swanepoel,
T.
Ksiazek,
S.
Nichol
(2002)
Genetic Analysis of Viruses Associated with Emergence of Rift Valley Fever in Saudi Arabia and Yemen, 2000-01
Emerging Infectious Diseases, 8
-
D.
Holman,
Danher
Wang,
N.
Raja,
Min
Luo,
K.
Moore,
J.
Woraratanadharm,
N.
Mytle,
John
Dong
(2008)
Multi-antigen vaccines based on complex adenovirus vectors induce protective immune responses against H5N1 avian influenza viruses.
Vaccine, 26 21
-
S.
Rubinchik,
J.
Norris,
J.
Dong
(2002)
Construction, purification and characterization of adenovirus vectors expressing apoptosis-inducing transgenes.
Methods in enzymology, 346
-
D.
Barouch,
M.
Pau,
J.
Custers,
W.
Koudstaal,
S.
Kostense,
M.
Havenga,
D.
Truitt,
Shawn
Sumida,
Michael
Kishko,
Janelle
Arthur,
Birgit
Korioth-Schmitz,
M.
Newberg,
D.
Gorgone,
M.
Lifton,
D.
Panicali,
G.
Nabel,
N.
Letvin,
J.
Goudsmit
(2004)
Immunogenicity of Recombinant Adenovirus Serotype 35 Vaccine in the Presence of Pre-Existing Anti-Ad5 Immunity1
The Journal of Immunology, 172
-
N.
Frank-Peterside
(2000)
Response of laboratory staff to vaccination with an inactivated Rift Valley fever vaccine--TSI-GSD 200.
African journal of medicine and medical sciences, 29 2
-
B.
Botros,
Adel
Omar,
K.
Elian,
G.
Mohamed,
A.
Soliman,
A.
Salib,
D.
Salman,
M.
Saad,
K.
Earhart
(2006)
Adverse response of non‐indigenous cattle of European breeds to live attenuated Smithburn Rift Valley fever vaccine
Journal of Medical Virology, 78
-
J.
Brown,
J.
Dominik,
R.
Morrissey
(1981)
Respiratory infectivity of a recently isolated Egyptian strain of Rift Valley fever virus
Infection and Immunity, 33
-
D.
Swenson,
Danher
Wang,
Min
Luo,
Kelly
Warfield,
J.
Woraratanadharm,
D.
Holman,
John
Dong,
W.
Pratt
(2008)
Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections
Clinical and Vaccine Immunology, 15
-
G.
Kobinger,
H.
Feldmann,
Yan
Zhi,
G.
Schumer,
G.
Gao,
F.
Feldmann,
S.
Jones,
James
Wilson
(2006)
Chimpanzee adenovirus vaccine protects against Zaire Ebola virus.
Virology, 346 2
-
D.
Ellis,
P.
Shirodaria,
E.
Fleming,
D.
Simpson
(1988)
Morphology and development of Rift Valley fever virus in vero cell cultures
Journal of Medical Virology, 24
-
David
Wallace,
C.
Ellis,
A.
Espach,
S.
Smith,
R.
Greyling,
Gerrit
Viljoen
(2006)
Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever.
Vaccine, 24 49-50
-
(2007)
Outbreak news. Rift Valley fever, Sudan--update.
Releve epidemiologique hebdomadaire, 82 48
-
Sonja
Gerrard,
S.
Nichol
(2006)
Synthesis, proteolytic processing and complex formation of N-terminally nested precursor proteins of the Rift Valley fever virus glycoproteins
Virology, 357
-
A.
Siam,
J.
Meegan,
K.
Gharbawi
(1980)
Rift Valley fever ocular manifestations: observations during the 1977 epidemic in Egypt.
British Journal of Ophthalmology, 64
-
M.
Habjan,
Nicola
Penski,
V.
Wagner,
M.
Spiegel,
Anna
Overby,
G.
Kochs,
J.
Huiskonen,
F.
Weber
(2009)
Efficient production of Rift Valley fever virus-like particles: The antiviral protein MxA can inhibit primary transcription of bunyaviruses.
Virology, 385 2
-
Danher
Wang,
M.
Hevey,
L.
Juompan,
C.
Trubey,
N.
Raja,
S.
Deitz,
J.
Woraratanadharm,
Min
Luo,
Hong-gang
Yu,
Benjamin
Swain,
K.
Moore,
John
Dong
(2006)
Complex adenovirus-vectored vaccine protects guinea pigs from three strains of Marburg virus challenges.
Virology, 353 2
-
J.
Kark,
Y.
Aynor,
C.
Peters
(1982)
A Rift Valley Fever Vaccine Trial. 1. Side Effects and Serologic Response Over a Six-Month Follow-Up
American Journal of Epidemiology, 116
-
Code of federal regulations title 21 , part 58
-
S.
Buchbinder,
D.
Mehrotra,
A.
Duerr,
D.
Fitzgerald,
R.
Mogg,
David
Li,
P.
Gilbert,
J.
Lama,
M.
Marmor,
C.
Rio,
M.
McElrath,
D.
Casimiro,
K.
Gottesdiener,
J.
Chodakewitz,
L.
Corey,
Michael
Robertson
(2008)
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
The Lancet, 372
-
Kazuaki
Takehara,
Mi-Kyung
Min,
Jane
Battlesa,
Kazuyoshi
Sugiyama,
Vince
Emery,
J.
Dalrymple,
D.
Bishop
(1989)
Identification of mutations in the M RNA of a candidate vaccine strain of Rift Valley fever virus.
Virology, 169 2
-
A.
Lemckert,
Shawn
Sumida,
L.
Holterman,
R.
Vogels,
D.
Truitt,
Diana
Lynch,
Anjali
Nanda,
Bonnie
Ewald,
D.
Gorgone,
M.
Lifton,
J.
Goudsmit,
M.
Havenga,
D.
Barouch
(2005)
Immunogenicity of Heterologous Prime-Boost Regimens Involving Recombinant Adenovirus Serotype 11 (Ad11) and Ad35 Vaccine Vectors in the Presence of Anti-Ad5 Immunity
Journal of Virology, 79
-
L.
Corey,
M.
McElrath,
J.
Kublin
(2009)
Post-step modifications for research on HIV vaccines.
AIDS, 23 1
-
S.
Capone,
A.
Meola,
B.
Ercole,
A.
Vitelli,
M.
Pezzanera,
L.
Ruggeri,
M.
Davies,
R.
Tafi,
C.
Santini,
A.
Luzzago,
T.
Fu,
A.
Bett,
S.
Colloca,
R.
Cortese,
A.
Nicosia,
A.
Folgori
(2006)
A Novel Adenovirus Type 6 (Ad6)-Based Hepatitis C Virus Vector That Overcomes Preexisting Anti-Ad5 Immunity and Induces Potent and Broad Cellular Immune Responses in Rhesus Macaques
Journal of Virology, 80
-
K.
Raviprakash,
Danher
Wang,
D.
Ewing,
D.
Holman,
Karla
Block,
J.
Woraratanadharm,
Lan
Chen,
C.
Hayes,
John
Dong,
K.
Porter
(2008)
A Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys against All Four Serotypes of Dengue Virus
Journal of Virology, 82
-
M.
Al-Hazmi,
E.
Ayoola,
M.
Abdurahman,
S.
Banzal,
J.
Ashraf,
Adil
El-Bushra,
A.
Hazmi,
Mohammed
Abdullah,
H.
Abbo,
A.
Elamin,
El-Tayeb
Al-Sammani,
M.
Gadour,
C.
Menon,
M.
Hamza,
I.
Rahim,
Magdy
Hafez,
M.
Jambavalikar,
Haider
Arishi,
A.
Aqeel
(2003)
Epidemic Rift Valley fever in Saudi Arabia: a clinical study of severe illness in humans.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 36 3
-
T.
Francis,
T.
Magill
(1935)
RIFT VALLEY FEVER
The Journal of Experimental Medicine, 62
-
Rodion
Gorchakov,
E.
Volkova,
N.
Yun,
O.
Petrakova,
N.
Linde,
S.
Paessler,
E.
Frolova,
I.
Frolov
(2007)
Comparative analysis of the alphavirus-based vectors expressing Rift Valley fever virus glycoproteins.
Virology, 366 1
-
D.
Holman,
Danher
Wang,
K.
Raviprakash,
N.
Raja,
Min
Luo,
Jianghui
Zhang,
K.
Porter,
John
Dong
(2006)
Two Complex, Adenovirus-Based Vaccines That Together Induce Immune Responses to All Four Dengue Virus Serotypes
Clinical and Vaccine Immunology, 14
-
C.
Schmaljohn,
M.
Parker,
W.
Ennis,
J.
Dalrymple,
M.
Collett,
Joann
Slizich,
A.
Schmaljohn
(1989)
Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins.
Virology, 170 1
-
Jennifer
Schepp-Berglind,
Min
Luo,
Danher
Wang,
J.
Wicker,
N.
Raja,
B.
Hoel,
D.
Holman,
A.
Barrett,
John
Dong
(2007)
Complex Adenovirus-Mediated Expression of West Nile Virus C, PreM, E, and NS1 Proteins Induces both Humoral and Cellular Immune Responses
Clinical and Vaccine Immunology, 14
-
L.
Kakach,
T.
Wasmoen,
M.
Collett
(1988)
Rift Valley fever virus M segment: use of recombinant vaccinia viruses to study Phlebovirus gene expression
Journal of Virology, 62
-
H.
Caplen,
C.
Peters,
D.
Bishop
(1985)
Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development.
The Journal of general virology, 66 ( Pt 10)
-
Z.
Xiang,
Guangping
Gao,
Arturo
Reyes-Sandoval,
Yan
Li,
James
Wilson,
Hildegund
Ertl
(2003)
Oral Vaccination of Mice with Adenoviral Vectors Is Not Impaired by Preexisting Immunity to the Vaccine Carrier
Journal of Virology, 77
-
M.
Gonçalves,
A.
Vries
(2006)
Adenovirus: from foe to friend
Reviews in Medical Virology, 16
-
P.
Bossi,
A.
Tegnell,
A.
Baka,
F.
Loock,
J.
Hendriks,
A.
Werner,
H.
Maidhof,
G.
Gouvras
(2004)
Bichat guidelines for the clinical management of haemorrhagic fever viruses and bioterrorism-related haemorrhagic fever viruses.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 9 12
-
R.
Muller,
J.
Saluzzo,
Nora
Lopez,
Thomas
Dreier,
M.
Turell,
Jonathan
Smith,
M.
Bouloy
(1995)
Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment.
The American journal of tropical medicine and hygiene, 53 4
-
Philip
Cohen
(2006)
Immunity's yin and yang. A successful vaccine must first avoid being eliminated by pre-existing immunity before it can promote a protective immune response.
IAVI report : newsletter on international AIDS vaccine research, 10 1
-
Danher
Wang,
N.
Raja,
C.
Trubey,
L.
Juompan,
Min
Luo,
J.
Woraratanadharm,
S.
Deitz,
Hong-gang
Yu,
Benjamin
Swain,
K.
Moore,
W.
Pratt,
M.
Hart,
John
Dong
(2005)
Development of a cAdVax-Based Bivalent Ebola Virus Vaccine That Induces Immune Responses against both the Sudan and Zaire Species of Ebola Virus
Journal of Virology, 80
-
P.
Pittman,
Ching-Tong
Liu,
T.
Cannon,
R.
Makuch,
J.
Mangiafico,
P.
Gibbs,
C.
Peters
(1999)
Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience.
Vaccine, 18 1-2
-
K.
Smithburn,
A.
Mahaffy
(1949)
Rift Valley fever; accidental infections among laboratory workers.
Journal of immunology, 62 2
-
H.
Balkhy,
Z.
Memish
(2003)
Rift Valley fever: an uninvited zoonosis in the Arabian peninsula.
International journal of antimicrobial agents, 21 2